TD Cowen Maintains Hold on Legend Biotech, Raises Price Target to $29
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
TD Cowen analyst Yaron Werber maintains Legend Biotech (NASDAQ:LEGN) with a Hold and raises the price target from $21 to $29.
TD Cowen analyst Yaron Werber maintains Legend Biotech (NASDAQ:LEGN) with a Hold and raises the price target from $21 to $29.